Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway
Cells · 2025
DOI: 10.3390/cells14020083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Ga Hee Jeong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Kor…. Hauptthemen laut MEDLINE: NF-kappa B, Signal Transduction, Anti-Inflammatory Agents, STAT Transcription Factors. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea (NRF), National Research Foundation of Korea (NRF) by the Ministry of Science, ICT.
Abstract (Originalsprache)
Cannabinoid compounds have potential as treatments for a variety of conditions, with cannabigerol (CBG) being known for its anti-inflammatory properties. In this study, we investigated the effects of CBG in a cellular model of 1-chloro-2,4-dinitrobenzene (DNCB)-induced atopic dermatitis (AD). In the cellular model, we confirmed the cytotoxicity of CBG and downregulated the expression of inflammatory markers CCL26, IL1B, IL6, and TNF (p < 0.001). In the mouse model, clinical, histological, and immunological changes were analyzed. The results showed that CBG improved dermatitis severity score, epidermal thickness, and mast cell count and reduced inflammatory cytokines (Tslp, Il1b, Il4, Il6, Il13, Il17, Il18, Il22, and Il33) by qRT-PCR (p < 0.001). Western blot results showed modulated changes in JAK1, JAK2, TYK2, STAT1, STAT2, STAT3, p-STAT3, STAT6, and p-STAT6 (p < 0.05). Subsequently, p-IκBα, NF-κB, and p-NF-κB signaling factors were also reduced (p < 0.05), with corresponding changes in skin barrier factors. The results of this study indicate that CBG effectively alleviates AD-like symptoms and suggest the potential of CBG as a therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
- Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, #222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
ORCID-Profile: Ga Hee Jeong, Ki Chan Kim, Ji Hyun Lee
Förderung
- the National Research Foundation of Korea (NRF)
- National Research Foundation of Korea (NRF) by the Ministry of Science, ICT
Zitieren
APA
Jeong, G. H., Kim, K. C., & Lee, J. H. (2025). Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway. Cells. https://doi.org/10.3390/cells14020083
Vancouver
Jeong GH, Kim KC, Lee JH. Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway. Cells. 2025. doi:10.3390/cells14020083
BibTeX
@article{Jeong2025,
author = {Jeong, Ga Hee and Kim, Ki Chan and Lee, Ji Hyun},
title = {Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14020083}
}
EUVIMED